Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms 7 Breast Neoplasms 7 Head and Neck Neoplasms 5 Glioblastoma 4 Squamous Cell Carcinoma of Head and Neck 3 Prostatic Neoplasms 3 Melanoma 3 Hematologic Neoplasms 3 Glioma 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Pancreatic Neoplasms 2 Oropharyngeal Neoplasms 2 Lymphedema 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hematopoietic and Lymphatic System Neoplasm 2 Carcinoma, Squamous Cell 2 Brain Neoplasms 2 Astrocytoma 2 Xeroderma Pigmentosum 1 Triple Negative Breast Neoplasms 1 Trichothiodystrophy Syndromes 1 Tongue Neoplasms 1 Spinal Cord Neoplasms 1 Smoking Cessation 1 Smoking 1 Signs and Symptoms, Digestive 1 Sexuality 1 Sexual Dysfunction, Physiological 1 Rectal Neoplasms 1

Interventions

Cytarabine 358 Cyclophosphamide 241 Azacitidine 213 fludarabine phosphate 199 venetoclax 198 fludarabine 196 Busulfan 148 Decitabine 132 Mycophenolic Acid 123 Whole-Body Irradiation 122 Peripheral Blood Stem Cell Transplantation 118 Tacrolimus 115 Granulocyte Colony-Stimulating Factor 104 Idarubicin 100 Filgrastim 100 Melphalan 89 Cyclosporine 89 Methotrexate 83 Daunorubicin 76 Antilymphocyte Serum 75 Etoposide 73 Mitoxantrone 67 Clofarabine 67 Gemtuzumab 59 Stem Cell Transplantation 55 Thiotepa 51 Cladribine 46 Injections 45 Specimen Handling 44 thymoglobulin 40

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Leukemia, Myeloid, Acute × Restraint, Physical × Clear all

NCT06786897 2025-01-22

ERAPH

University Hospital, Montpellier

Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡